long term side effects of glp-1 receptor agonists Common GLP-1 Weight-loss Side Effects
Description
NNC0090-2746 (RG7697) is a compound that has been tested in multiple preclinical and clinical studies as a dual GIPR/GLP-1R agonist [58,59,60]
(March 2016)
Thats because Mounjaro has a dual-action that activates GIP & GLP-1 receptors agonist, often described at dual-hormone injection
Fractions with a purity of greater than 95% were pooled and lyophilized
2022 Jul 6;10:950623
